PubMed:33430924 / 1691-1934 JSONTXT

{"project":"Inflammaging","denotations":[{"id":"T12","span":{"begin":0,"end":243},"obj":"Sentence"},{"id":"T12","span":{"begin":0,"end":243},"obj":"Sentence"}],"text":"BIO101, a 97% pharmaceutical grade 20-hydroxyecdysone could then offer a new therapeutic option by improving the respiratory function and ultimately promoting survival in COVID-19 patients that develop severe forms of this devastating disease."}